NetJets has expanded its partnership with Corporate Angel Network, giving more cancer patients access to treatment.
Since 1997, NetJets has supported the New York-based non-profit organization by donating hundreds of flight hours to cancer patients. The news of an expanded partnership means the company is giving Corporate Angel Network access to more flying opportunities, with the potential to double the amount of flights the organization offers.
Many patients that seek support from Corporate Angel Network live in remote locations, making it challenging to access major airports. Private jets make it possible for patients to arrive closer to medical centers, and return closer to home.
NetJets owners will continue to be able to donate their flight hours to the organization, and starting this year, NetJets will match owner flight hour donations up to 50 hours annually.
Adam Johnson, chairman and CEO, NetJets, said, “Corporate Angel Network is an extraordinary organization that makes it possible for cancer patients to get the life-saving treatment they need.
“As a parent, I can only imagine how devastating it is to care for a sick child while dealing with the many challenges and obstacles that can interrupt access to medical care.
“It is our privilege to support the incredible efforts of Corporate Angel Network by providing expanded access to flight operations.”
Gina Russo, executive director, Corporate Angel Network, commented, “Corporate Angel Network recently completed its 55,000th cancer patient flight. Our success over the years is possible because of the dedication and efforts of many volunteers, as well as the support we receive from companies that share their ’empty seats’ with patients.
“For 20 years, NetJets has been one of our greatest supporters and we are thrilled that with the help of their network of travel providers, we will be able to help even more families in need.
“On behalf of all the patients we serve, Corporate Angel Network would like to express its gratitude to the entire NetJets family for their generosity and support. Thanks to their partnership, we are breaking down barriers to treatment, pushing the science forward and removing some of the burden that comes with a cancer diagnosis.”
